Industry events throughout the year play a crucial role in fostering innovation and driving progress in health care. AdvaMed, host of The MedTech Conference, is proud to support these opportunities, including most recently at LSI USA ‘25, which brought together innovators, investors, and industry leaders in Dana Point, California. This dynamic event served as a powerful platform for exchanging ideas and exploring the groundbreaking advancements shaping the future of medtech.

Intersections of Innovation and Opportunity

The summit showcased an impressive array of emerging medtech companies, each presenting groundbreaking solutions poised to revolutionize health care. Hundreds of startups delivered pitches of their products to potential investors and partners, offering a glimpse into the future of health care. This dynamic environment underscored the sector’s commitment to addressing unmet medical needs through technological advancements.

Industry Trends and Investment Climate

The medtech industry is experiencing a period of robust growth and transformation. The global medtech market size is projected to expand from $668.2 billion in 2024 to $694.7 billion by 2025, reflecting a year-over-year increase of approximately 4%(MarketsandMarkets via PR Newswire). This growth is fueled by several key trends:

• Artificial Intelligence and Machine Learning: AI and ML are revolutionizing diagnostics, treatment planning, and patient monitoring, leading to more personalized and efficient health care solutions.
• Strategic Mergers and Acquisitions: The industry is witnessing a resurgence in M&A activity, with companies focusing on expanding product lines and entering new markets to bolster their competitive edge.
• Continued Technology Innovation: Advancements in areas such as cardiovascular disease, women’s health, diabetes care, orthopedics, digital health solutions, to name a few.

One of the most inspiring aspects of the summit was witnessing how small and emerging companies are driving innovation at an unprecedented pace. Their agility allows them to rapidly develop and iterate novel technologies, addressing specific health care challenges with precision and creativity. This trend not only accelerates the availability of cutting-edge solutions but also attracts significant investment, as evidenced by the substantial funds raised by LSI alumni companies in recent weeks (Life Science Market Research).

DeChane Dorsey, AdvaMed Accel Executive Director, also joined a session on small company issues and the new administration, with speakers Lishan Aklog, Chairman & CEO, PAVmed, and Juliana Elstad, CEO, Vibrato Medical. While the LSI conference generated significant buzz and provided many valuable takeaways, there was a lot of discussion about the changing health care landscape. Stay informed on these critical issues by joining AdvaMed and attending The MedTech Conference to connect with professionals facing similar challenges.

Expanding Opportunities at The MedTech Conference

While LSI USA provides an excellent platform for early-stage companies to gain visibility, The MedTech Conference—happening this fall—offers an unparalleled opportunity for these innovators to deepen industry relationships, connect with strategic partners, and explore commercialization pathways. Investors looking to identify the next breakthrough in medtech will find The MedTech Conference to be a must-attend event, featuring:

• Market Access & Policy Insights: Join exclusive sessions that provide critical updates on the investment landscape, medtech innovation trends, medtech M&A, regulatory trends, reimbursement strategies, global market expansion, and more.
• Investor & Strategic Partnering: A robust networking program designed to facilitate one-on-one meetings between startups, investors, and established medtech leaders.
• Showcase of the Future of Medtech: Top startups and industry leaders will take the stage to share their latest innovations to a global audience of medtech investors and key decision-makers. Early and commercial-stage companies looking to elevate their business to future partners can apply now to give a 9-minute Company Presentation.

For emerging companies, this conference represents a critical next step in scaling innovations from concept to commercialization. The insights and relationships gained at LSI can be further refined and leveraged at The MedTech Conference, where deals get done and partnerships are forged.

Looking Ahead

The energy and enthusiasm at LSI USA ’25 reaffirmed the medtech industry’s resilience and its unwavering commitment to improving patient care through innovation. As we navigate the evolving landscape, the collaborations and insights gained from this summit—and carried forward to The MedTech Conference—will undoubtedly play a pivotal role in shaping the future of health care.

Beth Perkins is the Senior Director of Business Development & Investor Relations for
The MedTech Conference and AdvaMed, dedicated to fostering strategic partnerships and advancing investment in medical technology innovations.